Antileukinate is primarily used in research settings to study the role of leukocyte chemotaxis in inflammatory processes. It acts as an inhibitor of interleukin-8 (IL-8), a chemokine that plays a critical role in attracting neutrophils to sites of inflammation. By blocking IL-8 activity, Antileukinate helps researchers understand the mechanisms underlying inflammatory diseases such as rheumatoid arthritis, psoriasis, and chronic obstructive pulmonary disease (COPD). Additionally, it is utilized in experimental models to explore potential therapeutic strategies for conditions driven by excessive neutrophil recruitment. Its application extends to studying cancer metastasis, as IL-8 is also implicated in tumor progression and angiogenesis.